Código QR (código de barras bidimensional)

Real-world effectiveness of SGLT2 inhibitors in patients with HF and ESKD: a multicenter cohort study

BackgroundPatients with heart failure (HF) and end-stage kidney disease (ESKD) face a high burden of mortality and hospitalization, yet effective therapeutic options remain limited. While sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated cardiovascular and renal benefits across va...

ver descrição completa

Na minha lista:
Principais autores: Jheng-Yan Wu, Kuan-Jui Tseng, Chia-Li Kao, Kuo-Chuan Hung, Tsung Yu, Yu-Min Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-01-01
coleção:Frontiers in Cardiovascular Medicine
Assuntos:
end-stage kidney disease
heart failure
major adverse cardiovascular events
major adverse kidney events
sodium-glucose cotransporter-2 inhibitors
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fcvm.2026.1652863/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados